NO20092465L - Hyaluronsyreregel for intradermal injeksjon - Google Patents

Hyaluronsyreregel for intradermal injeksjon

Info

Publication number
NO20092465L
NO20092465L NO20092465A NO20092465A NO20092465L NO 20092465 L NO20092465 L NO 20092465L NO 20092465 A NO20092465 A NO 20092465A NO 20092465 A NO20092465 A NO 20092465A NO 20092465 L NO20092465 L NO 20092465L
Authority
NO
Norway
Prior art keywords
hyaluronic acid
intradermal injection
rule
acid rule
injectable
Prior art date
Application number
NO20092465A
Other languages
English (en)
Norwegian (no)
Inventor
Estelle Piron
Patrick Bogdanowicz
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38198256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092465(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of NO20092465L publication Critical patent/NO20092465L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
NO20092465A 2006-12-06 2009-06-30 Hyaluronsyreregel for intradermal injeksjon NO20092465L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0610645A FR2909560B1 (fr) 2006-12-06 2006-12-06 Gel d'acide hyaluronique pour injection intradermique
PCT/EP2007/063384 WO2008068297A1 (fr) 2006-12-06 2007-12-06 Gel d'acide hyaluronique pour injection intradermique

Publications (1)

Publication Number Publication Date
NO20092465L true NO20092465L (no) 2009-06-30

Family

ID=38198256

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092465A NO20092465L (no) 2006-12-06 2009-06-30 Hyaluronsyreregel for intradermal injeksjon

Country Status (22)

Country Link
US (1) US20100316683A1 (de)
EP (2) EP2152329B1 (de)
JP (1) JP5642388B2 (de)
KR (2) KR101642622B1 (de)
CN (1) CN101594892A (de)
AR (1) AR064175A1 (de)
AU (1) AU2007328917B2 (de)
BR (1) BRPI0720176A2 (de)
CA (1) CA2671793A1 (de)
ES (1) ES2632947T3 (de)
FR (1) FR2909560B1 (de)
IL (1) IL199002A (de)
MA (1) MA30978B1 (de)
MX (1) MX2009005894A (de)
NO (1) NO20092465L (de)
NZ (1) NZ577917A (de)
RU (1) RU2448740C2 (de)
TN (1) TN2009000223A1 (de)
TW (1) TWI430815B (de)
UA (1) UA95660C2 (de)
WO (1) WO2008068297A1 (de)
ZA (1) ZA200903919B (de)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
WO2008147867A2 (en) 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
US20110077737A1 (en) * 2007-07-30 2011-03-31 Allergan, Inc. Tunably Crosslinked Polysaccharide Compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
CN101918032A (zh) * 2007-12-21 2010-12-15 恩希瑟有限公司 含有活性物质的交联水凝胶
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2015252122A1 (en) * 2008-08-04 2015-11-26 Allergan Industrie Sas Hyaluronic acid-based gels including anesthetic agents
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
WO2010115081A2 (en) * 2009-04-02 2010-10-07 Allergan, Inc. Hair-like shaped hydrogels for soft tissue augmentation
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171310A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
AU2015255189B2 (en) * 2010-03-12 2017-05-25 Allergan Industrie Sas A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
CN102905677A (zh) * 2010-03-12 2013-01-30 阿勒根工业有限公司 用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物
ES2585388T5 (es) * 2010-03-22 2019-08-08 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
WO2012008722A2 (ko) * 2010-07-12 2012-01-19 신풍제약 주식회사 조직 증강용 충전 조성물
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
PT2637710T (pt) * 2010-11-08 2017-07-12 Allergan Ind Sas Formulações à base de ácido hialurónico
EP2484387A1 (de) * 2011-02-03 2012-08-08 Q-Med AB Hyaluronsäurezusammensetzung
EP2606828B1 (de) * 2011-12-20 2018-04-11 Angioclinic AG Hyaluronsäure und deren Verwendung bei der Behandlung von Veneninsuffizienz und Krampfadern
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
KR102312056B1 (ko) * 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
AU2012308503B2 (en) * 2011-09-14 2015-08-13 Allergan Industrie, Sas Dermal filler compositions for fine line treatment
WO2013092872A2 (en) * 2011-12-22 2013-06-27 L'oreal Cosmetic processes with glucosamine-based hydrogels
CN103181902B (zh) * 2011-12-30 2016-06-08 张文芳 一种凝胶微球及其质控方法
WO2013185934A1 (en) * 2012-06-15 2013-12-19 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
FR2994846B1 (fr) * 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法
CN103006544B (zh) * 2012-12-21 2014-07-09 上海景峰制药股份有限公司 一种高粘弹性玻璃酸钠凝胶制备方法
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby
EP3107587B1 (de) * 2014-02-20 2019-03-27 Mastelli S.r.l. Dermokosmetische füllmasse und ihre verwendung für ästhetische zwecke
US20150258200A1 (en) * 2014-03-14 2015-09-17 Taiwan Biomaterial Company Ltd. Pressure-sensitive hydrogel and method of use
AR099900A1 (es) 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
FR3020570B1 (fr) * 2014-04-30 2017-07-21 Pierre Fabre Dermo Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
KR101641299B1 (ko) * 2014-06-25 2016-07-20 김동진 금속 코팅 가시매선
CN104086788B (zh) * 2014-07-17 2016-08-17 华熙福瑞达生物医药有限公司 一种注射用修饰透明质酸钠凝胶
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
BR112017016655B1 (pt) * 2015-02-13 2022-05-03 Endo Derma Co., Ltd Micro-agulha biodegradável contendo hidrogel de ácido hialurônico reticulado e método para sua preparação
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr) * 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
WO2017001057A1 (en) 2015-06-30 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
WO2017016917A1 (en) 2015-07-27 2017-02-02 Galderma Sa A process for efficient cross-linking of hyaluronic acid
RU2703726C2 (ru) * 2015-08-06 2019-10-22 Лаборатори Деривати Органичи Спа Композиции, содержащие дерматансульфат и хондроитинсульфат, и их применение в косметологических композициях
CN105107018B (zh) * 2015-08-19 2018-08-24 李媚 一种无菌可注射材料的制备方法
EP3165233B1 (de) * 2015-08-28 2021-08-18 Latvijas Universitate Biomaterial zur behandlung von akuten und chronischen hautwunden
JP6660469B2 (ja) 2015-11-24 2020-03-11 ビーエムアイ コリア カンパニー リミテッド ヒアルロン酸誘導体およびｄｎａ分画物が含まれているヒアルロン酸注射用組成物およびその利用
EP3397651B1 (de) 2015-12-29 2020-05-06 Galderma S.A. Kohlenhydratvernetzer
TWI727014B (zh) 2016-03-24 2021-05-11 德商梅茲製藥有限兩合公司 修飾透明質酸與其製造方法及其用途
CA2961868A1 (en) * 2016-04-08 2017-10-08 Johnson & Johnson Consumer Inc. Topical compositions containing cross-linked glycosaminoglycans
KR101660211B1 (ko) * 2016-06-07 2016-09-26 동국제약 주식회사 단일상과 이성상의 특성을 동시에 갖는 히알루론산 가교체, 이의 제조 방법 및 이의 용도
WO2017217818A1 (ko) 2016-06-16 2017-12-21 주식회사 엔도더마 용해 특성이 우수한 히알루론산 마이크로구조체
CN106074213A (zh) * 2016-06-24 2016-11-09 上海建华精细生物制品有限公司 用于水光注射的透明质酸钠凝胶及其制备方法和应用
AU2017315431B2 (en) 2016-08-24 2020-06-25 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
KR20180055938A (ko) * 2016-11-09 2018-05-28 김주홍 주름 제거용 패치
KR101718483B1 (ko) 2016-12-21 2017-04-05 주식회사 동방메디컬 니들 패치의 제조방법 및 이 방법으로 제조된 니들 패치
KR101921246B1 (ko) * 2017-01-04 2018-11-22 주식회사 베스트앤퍼스트바이오텍 탈모 방지 및 양모를 위한 헤어 필러 조성물 및 그 제조 방법
CN110621355B (zh) * 2017-02-28 2022-01-21 Cg生物技术有限公司 皮肤注入用组合物
CN107522881B (zh) * 2017-08-16 2020-05-05 杭州协合医疗用品有限公司 制备单相修饰透明质酸钠凝胶的方法
AU2018391673B2 (en) * 2017-12-22 2024-07-11 Galderma Holding SA Injectable gel product
CN108261341A (zh) * 2018-02-12 2018-07-10 苏州纳晶医药技术有限公司 双组份用于纠正皮肤皱纹的美白长效水光针剂
EP3787702B1 (de) 2018-05-03 2024-08-07 CollPlant Ltd. Dermale füllstoffe und deren anwendungen
ES3061777T3 (en) 2018-06-15 2026-04-07 Croma Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
WO2019238954A1 (en) * 2018-06-15 2019-12-19 Croma-Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
US20210260244A1 (en) 2018-06-29 2021-08-26 Merz Pharma Gmbh & Co. Kgaa Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof
TWI708607B (zh) * 2018-07-06 2020-11-01 南韓商Ｌｇ化學股份有限公司 同時具有高度黏彈性和內聚性之玻尿酸填料
ES3064507T3 (en) 2018-08-07 2026-04-27 Merz Pharma Gmbh & Co Kgaa Method for dynamic filtration of a cross-linked hydrogel
CA3122116C (en) * 2018-12-20 2023-07-18 Lg Chem, Ltd. Filler having excellent filler properties comprising hyaluronic acid hydrogel
BR112021018691A2 (pt) * 2019-03-24 2021-11-23 Allergan Pharmaceuticals Int Ltd Géis homogêneos injetáveis compreendendo formas múltiplas de ácido hialurônico e métodos para sua fabricação
CN111068114B (zh) * 2019-12-26 2022-05-03 浙江景嘉医疗科技有限公司 一种含甘露醇的注射用修饰透明质酸钠凝胶的制备方法
RU2731527C1 (ru) * 2020-01-28 2020-09-03 Кирилл Александрович Новиков Способ устранения рубцовых изменений кожи
BR102020003483A2 (pt) * 2020-02-19 2021-08-31 Marco Antonio Bittencourt Implantes subcutâneos para liberação lenta e controlada de ativos.
FR3128373A1 (fr) 2021-10-22 2023-04-28 Jr Composition pour son utilisation dans la synthese cutanee d’acide hyaluronique, dans la reponse immuno-cutanee et une amelioration de la peau
CN119032122A (zh) * 2022-03-11 2024-11-26 株式会社界优维 糊状组合物、生物降解性注射用糊剂及其制备方法
DE102022113526A1 (de) * 2022-05-30 2023-11-30 Louna Aesthetics SAS Verfahren zur Herstellung einer Zusammensetzung, Zusammensetzung und Verwendung der Zusammensetzung
CN116098827B (zh) * 2022-12-07 2025-04-04 华熙生物科技股份有限公司 寡肽在提高维生素和/或氨基酸稳定性中的应用
CN115944553B (zh) * 2022-12-07 2024-12-31 华熙生物科技股份有限公司 寡肽在提高交联透明质酸或其盐稳定性中的应用
CN120771345B (zh) * 2025-09-09 2025-12-16 深圳市琉璃光生物科技有限公司 一种用于皮肤美容的注射用透明质酸钠复合溶液的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
US5143744A (en) * 1991-06-19 1992-09-01 Minnesota Mining And Manufacturing Company Dynamic contact angle measurement system
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
FR2733427B1 (fr) * 1995-04-25 2001-05-25 W K Et Associes Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique
JPH11279042A (ja) 1998-03-30 1999-10-12 Shiseido Co Ltd 皮膚外用剤
FR2778336A1 (fr) * 1998-05-11 1999-11-12 Jean Pierre Perraud Implant injectable en sous-cutane et en sous-gingival resorbable a base de maltodextrine micro-encapsulee et resorbable en un temps determine
FR2780730B1 (fr) * 1998-07-01 2000-10-13 Corneal Ind Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
FR2811996B1 (fr) * 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
US7820194B2 (en) * 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US20040092222A1 (en) * 2002-11-07 2004-05-13 Bogdan Kowalczyk Stationary head for a disc-type coin processing device having a solid lubricant disposed thereon
FR2850282B1 (fr) * 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
AU2003206922A1 (en) * 2003-02-19 2004-09-09 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
FR2861734B1 (fr) * 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) * 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
WO2005066215A1 (en) 2003-12-30 2005-07-21 Genzyme Corporation Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use
FR2865651B1 (fr) 2004-01-29 2007-09-28 Fabre Pierre Dermo Cosmetique Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale
FR2865737B1 (fr) 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제
US20050281880A1 (en) * 2004-05-20 2005-12-22 Wei Wang Methods for making injectable polymer hydrogels
FR2873379B1 (fr) * 2004-07-23 2008-05-16 Jerome Asius Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation
KR101239037B1 (ko) * 2004-11-15 2013-03-04 가부시키가이샤 시세이도 가교 히알루론산 겔의 제조 방법
US20060105022A1 (en) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
US8481080B2 (en) * 2004-11-24 2013-07-09 Novozymes Biopolymer A/S Method of cross-linking hyaluronic acid with divinulsulfone
FR2883003B1 (fr) * 2005-03-14 2008-04-11 Aldivia Sa Nouveaux antioxydants a base d'especes d'anacardiacees, plus particulierement de sclerocarya birrea, leurs procedes d'obtention et leurs applications

Also Published As

Publication number Publication date
CA2671793A1 (fr) 2008-06-12
IL199002A0 (en) 2010-02-17
MX2009005894A (es) 2009-09-10
UA95660C2 (ru) 2011-08-25
IL199002A (en) 2013-01-31
TWI430815B (zh) 2014-03-21
KR20140101018A (ko) 2014-08-18
CN101594892A (zh) 2009-12-02
JP5642388B2 (ja) 2014-12-17
KR20090085102A (ko) 2009-08-06
BRPI0720176A2 (pt) 2013-12-24
ZA200903919B (en) 2010-06-30
RU2448740C2 (ru) 2012-04-27
AR064175A1 (es) 2009-03-18
EP2152329A1 (de) 2010-02-17
EP2152329B1 (de) 2017-02-15
EP2489374A1 (de) 2012-08-22
TN2009000223A1 (fr) 2010-10-18
AU2007328917A1 (en) 2008-06-12
TW200836778A (en) 2008-09-16
WO2008068297A1 (fr) 2008-06-12
FR2909560A1 (fr) 2008-06-13
MA30978B1 (fr) 2009-12-01
NZ577917A (en) 2012-01-12
US20100316683A1 (en) 2010-12-16
KR101642622B1 (ko) 2016-07-25
AU2007328917B2 (en) 2012-08-02
JP2010511454A (ja) 2010-04-15
FR2909560B1 (fr) 2012-12-28
ES2632947T3 (es) 2017-09-18
RU2009125201A (ru) 2011-01-20
KR101642516B1 (ko) 2016-07-25

Similar Documents

Publication Publication Date Title
NO20092465L (no) Hyaluronsyreregel for intradermal injeksjon
CY1123255T1 (el) Σχημα δοσολογιας για εναν αγωνιστη υποδοχεα s1p
CY1118821T1 (el) Γελες με βαση υαλουρονικο οξυ οι οποιες περιλαμβανουν αναισθητικους παραγοντες
MX340148B (es) Composición de ácido hialurónico.
DE602004013257D1 (de) Implantate mit lebender Gewebe zur Reparatur von Gewebeschäden oder Gewebedefekten
BR112017022623A2 (pt) implantes de córnea
EA201000953A1 (ru) Медицинский электрод, пучок электродов и массив из пучков электродов
BRPI0917535A8 (pt) uso de insulina de ação ultra rápida
GB201212125D0 (en) Abutment system and dental methods
BRPI0906414A2 (pt) Unidade de parafuso pedicular para posicionar um membro alongado dentro de um paciente, e, implante
DE602007010340D1 (de) Implantierbares medizinisches längliches element mit expandierbaren befestigungselementen
EA201100765A1 (ru) Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
EP2480565A4 (de) Peptidomimetische makrozyklen
CY1116344T1 (el) Κυτταρα προερχομενα απο ιστο ομφαλιου λωρου για την θεραπεια νευροπαθητικου πονου και σπαστικοτητας
WO2012008722A3 (ko) 조직 증강용 충전 조성물
BRPI0914950A2 (pt) implantes, sistemas e técnicas de aumento da vantagem mecânica de parafusos ósseos
AR070198A1 (es) Elaboracion de enzimas lisosomales sulfatasa humanas activas y altamente fosforiladas y sus usos
BRPI0920138A2 (pt) lente intraocular, e, métodos para fabricar uma lente intraocular, e para inserir uma lente intraocular em um paciente
BRPI0807709B8 (pt) método para tratamento de tecido biológico de origem animal ou humana e tecido biológico de origem animal ou humana para uso como implante em corpo humano ou animal
BR112014007675A2 (pt) tratamento de doença articular degenerativa
BR112013003160A2 (pt) tratamento de diabetes com células precursoras endócrinas pancráticas
EP2455755A3 (de) Proteoglycan-4 als Marker für chronischens Nierenversagen
CY1112058T1 (el) Χρηση των χιτοζανων για την αυξηση του βαθμου αναπτυξης των νυχιων
MX2014004994A (es) Cisteamina en el tratamiento de enfermedad fibrotica.
WO2011146926A3 (en) Systems and methods for treatment of sleep apnea

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application